Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00150397 · ClinicalTrials.gov registry record · Phase 2

A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

A Phase 2 study of Asthma, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
112
Enrollment target
20
Study locations

NCT00150397 is a Phase 2 study of Asthma that has completed, run by Pfizer. The registered enrollment target is 112 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00150397, a Phase 2 study of Asthma, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
112 participants
Enrollment target
20
Study locations

Study Summary

This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthma

Conditions Studied

Asthma

Interventions

  • DRUG Tofimilast

Study Locations (20)

California

  • Pfizer Investigational Site - Encinitas
  • Pfizer Investigational Site - Riverside

Massachusetts

  • Pfizer Investigational Site - North Dartmouth
  • Pfizer Investigational Site - Springfield

Tennessee

  • Pfizer Investigational Site - Kingsport
  • Pfizer Investigational Site - Nashville

Provincia de San José

  • Pfizer Investigational Site - Barrio Aranjuez
  • Pfizer Investigational Site - San José

Florida

  • Pfizer Investigational Site - DeLand

Georgia

  • Pfizer Investigational Site - Atlanta

Illinois

  • Pfizer Investigational Site - Normal

Kentucky

  • Pfizer Investigational Site - Madisonville

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2005-03
Est. Completion 2005-11
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00150397

The ClinicalTrials.gov registry entry for NCT00150397 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Tofimilast is the first listed.

NCT00150397 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Massachusetts, Tennessee.

Frequently Asked Questions

What is clinical trial NCT00150397 about?

NCT00150397 is a clinical study titled "A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics". This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthma

What is the current status of trial NCT00150397?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 112 participants. The study started on 2005-03. Estimated completion is 2005-11.

What conditions does trial NCT00150397 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00150397?

The interventions under investigation include: Tofimilast (DRUG).

Who is sponsoring clinical trial NCT00150397?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00150397 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.